Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      MSD India appoints Rehan A Khan as Managing Director

      MSD India appoints Rehan A Khan as Managing Director

      Medical Dialogues Bureau10 Jan 2020 12:04 PM IST
      Rehan A Khan was also a board member and advisor to several impacts led Private Equity funds and to healthcare companies in Africa, India, and...
      Abbott gets USFDA nod for less-invasive surgical approach for heart pump

      Abbott gets USFDA nod for less-invasive surgical approach for heart pump

      Medical Dialogues Bureau9 Jan 2020 3:32 PM IST
      New Delhi: Abbott recently announced U.S. Food and Drug Administration (USFDA) approval of a new alternative surgical technique for Abbott's HeartMate...
      Aleor Derma Karakhadi unit clears USFDA inspection

      Aleor Derma Karakhadi unit clears USFDA inspection

      Medical Dialogues Bureau9 Jan 2020 1:33 PM IST
      Mumbai: Drugmaker Alembic Pharma recently informed the bourses that its Joint Venture, Aleor Dermaceutical has successfully completed the US drug...
      Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

      Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

      Medical Dialogues Bureau9 Jan 2020 9:30 AM IST
      Until joining Strides Pharma, Dr R Ananthanarayanan was the Global Chief Operating Officer at Cipla Limited.Bangalore: Strides Pharma Science Limited...
      Streamline tax and duty structure in Union Budget 2020-21 to ensure quality medical devices: MTaI

      Streamline tax and duty structure in Union Budget 2020-21 to ensure quality medical devices: MTaI

      Medical Dialogues Bureau9 Jan 2020 9:24 AM IST
      "High customs duties have adversely impacted the costs of medical devices and equipment in India which contradicts the government's efforts to provide...
      Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran

      Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran

      Medical Dialogues Bureau9 Jan 2020 9:22 AM IST
      New Delhi: Novartis AG (Novartis) recently announced that it has completed the acquisition of The Medicines Company (the “Company”) through the...
      Esteve to buy German pharma firm Riemser from Ardian

      Esteve to buy German pharma firm Riemser from Ardian

      Medical Dialogues Bureau9 Jan 2020 9:00 AM IST
      Riemser specialises in oncology, neurology, and infectiology and had since 2012 been part of Ardian's portfolio. Ardian in 2018 unsuccessfully tried...
      Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg Report

      Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg Report

      Medical Dialogues Bureau8 Jan 2020 2:10 PM IST
      Arena Pharmaceuticals Inc. shares have nearly tripled since Chief Executive Amit Munshi took the helm in 2016 and now he’s setting a new course as the...
      Daiichi Sankyo introduces Enhertu - breast cancer drug in US

      Daiichi Sankyo introduces Enhertu - breast cancer drug in US

      Medical Dialogues Bureau8 Jan 2020 2:08 PM IST
      Tokyo and Basking Ridge, NJ – Daiichi Sankyo announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody-drug conjugate, is...
      Keytruda plus chemotherapy results in statistically significant improvement in PFS compared to chemotherapy alone

      Keytruda plus chemotherapy results in statistically significant improvement in PFS compared to chemotherapy alone

      Medical Dialogues Bureau8 Jan 2020 2:05 PM IST
      NJ- Merck has announced that the Phase 3 KEYNOTE-604 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met...
      Antiepileptic drug Lamotrigine will have to carry warning for hemophagocytic lymphohistiocytosis: CDSCO

      Antiepileptic drug Lamotrigine will have to carry warning for hemophagocytic lymphohistiocytosis: CDSCO

      Medical Dialogues Bureau8 Jan 2020 11:42 AM IST
      New Delhi: Commonly used bipolar disorder and epilepsy bipolar drug Lamotrigine will have to now carry mandatory safety alert in its leaflet regarding...
      Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

      Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

      Medical Dialogues Bureau7 Jan 2020 3:26 PM IST
      In addition to the investment, Everstone Managing Directors Arjun Oberoi and Puncham Mukim will join Slayback Pharma's Board of Directors. Everstone...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok